These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Importance of thrombocyte aggregation in altering the fibrinolytic activity and nonenzymatic fibrinolysis of the blood plasma]. Pastorova VE; Bazaz'ian GG; Romanovskiĭ AA Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (8):58-61. PubMed ID: 6215958 [No Abstract] [Full Text] [Related]
4. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro. Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475 [TBL] [Abstract][Full Text] [Related]
5. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis. Ambrus JL; Ambrus CM; Sharma SD; Suh OW; Gastpar H J Med; 1982; 13(5-6):365-71. PubMed ID: 6221055 [TBL] [Abstract][Full Text] [Related]
6. Profibrinolytic and antifibrinolytic effects of platelets. Devine DV; Carter CJ Coron Artery Dis; 1995 Dec; 6(12):915-22. PubMed ID: 8723012 [TBL] [Abstract][Full Text] [Related]
7. [Effect of parmidine (pyridinolcarbamate) on thrombocyte aggregation, blood clotting and fibrinolysis]. Mashkovskiĭ MD; Lakin KM; Ovnatanova MS; Shvarts GIa Biull Eksp Biol Med; 1976 Mar; 81(3):322-4. PubMed ID: 953280 [No Abstract] [Full Text] [Related]
8. [In vitro aggregation of rat platelets by cumulative doses of ADP: influence of 3 antiaggregants and a protease inhibitor, aprotinin]. Mary A; Cros G; Modat G; Lalaurie M C R Seances Soc Biol Fil; 1983; 177(3):320-31. PubMed ID: 6193845 [TBL] [Abstract][Full Text] [Related]
10. [Effect of recombinant urokinase activator plasminogen on the platelet aggregation and increase of the intracellular calcium level]. Zubkov AV; Bushueva TL; Minashkin MM; Gurskiĭ IaG; Men'shikov MIu Biull Eksp Biol Med; 1999 Sep; 128(9):339-43. PubMed ID: 10560061 [No Abstract] [Full Text] [Related]
11. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. McGowen R; Biliran H; Sager R; Sheng S Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285 [TBL] [Abstract][Full Text] [Related]
12. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors. Walker JB; Bajzar L J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009 [TBL] [Abstract][Full Text] [Related]
13. [Effect of 11-deoxymisoprostol ethyl ether sodium salt on thrombocyte aggregation and prothrombin time]. Gabdrakhmanova SF; Makara NS; Sapozhnikova TV; Baschenko NZh; Nazarov VS; Zarudiĭ FS Eksp Klin Farmakol; 2008; 71(2):40-2. PubMed ID: 18488906 [TBL] [Abstract][Full Text] [Related]
14. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation. Day JR; Haskard DO; Taylor KM; Landis RC Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862 [TBL] [Abstract][Full Text] [Related]
17. Metergoline: a strong inhibitor of rat thrombocyte aggregation "in vitro.". Doni MG Haematologica; 1980 Dec; 65(6):717-24. PubMed ID: 6790362 [No Abstract] [Full Text] [Related]
18. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation. Suehiro A; Sawada A; Hasegawa Y; Takatsuka H; Higasa S; Kakishita E Bone Marrow Transplant; 2002 Jan; 29(2):107-11. PubMed ID: 11850703 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets. Li BY; Bai Y; Li WH Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761 [TBL] [Abstract][Full Text] [Related]
20. The biological activity of antithrombotic agents immobilized on polymer surfaces. Kim SW; Ebert CD; McRea JC; Briggs C; Byun SM; Kim HP Ann N Y Acad Sci; 1983; 416():513-24. PubMed ID: 6233925 [No Abstract] [Full Text] [Related] [Next] [New Search]